![Caroline Loew](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Caroline J.
Loew worked at Bristol Myers Squibb Co. as Vice President & Head-Research from 2015 to 2018.
From 2018 to 2022, Dr. Loew was President, Chief Executive Officer & Director at Glympse Bio, Inc. Dr. Loew served as Director at Mural Oncology Plc in 2023.
Dr. Loew completed undergraduate and doctorate degrees at Imperial College London.
Eerdere bekende functies van Caroline Loew
| Bedrijven | Functie | Einde |
|---|---|---|
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Algemeen Directeur | 01-08-2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-10-2018 |
Opleiding van Caroline Loew
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
22
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Health Technology |
